AI drug developer Basecamp secures $140 million funding, reaching a valuation of $800 million, showcasing a promising future in healthcare.
Business Inforamtion
Business Inforamtion
AI drug developer Basecamp secures $140 million funding, reaching a valuation of $800 million, showcasing a promising future in healthcare.